Rare Earth Medical wins SBIR grant from NIH for fiber delivery system
The National Cancer Institute of the National Institutes of Health (NIH) awarded Rare Earth Medical (Dennis, MA) a $748,000 Phase II SBIR contract for the commercialization of a fiber optic laser light delivery system to be used for therapeutic treatments in oncology and cardiology. The system includes diffusers, known as Lightstics, that spread laser output along a cylindrical geometry. The two-year contract will fund further development of the technology, including testing at the Roswell Park
The National Cancer Institute of the National Institutes of Health (NIH) awarded Rare Earth Medical (Dennis, MA) a $748,000 Phase II SBIR contract for the commercialization of a fiber optic laser light delivery system to be used for therapeutic treatments in oncology and cardiology. The system includes diffusers, known as Lightstics, that spread laser output along a cylindrical geometry. The two-year contract will fund further development of the technology, including testing at the Roswell Park Cancer Institute (Buffalo, NY) and clinical trials at the University of Texas (Galveston, TX). Additional trials and tests are being conducted in the Netherlands and Germany.
